ロード中...
Phase I study of oral S-1 and concurrent radiotherapy in patients with head and neck cancer
This study investigated the maximum tolerated dose (MTD) of S-1 with concurrent radiotherapy in patients with head and neck cancer, based on the frequency of dose-limiting toxicities (DLT). S-1 was administered orally at escalating doses from 40 mg/m(2) b.i.d. on the days of delivering radiotherapy,...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3709662/ https://ncbi.nlm.nih.gov/pubmed/23292146 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jrr/rrs133 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|